Morrell Martha
CHIEF MEDICAL OFFICER
Morrell Martha has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.
On the most recent filing, Morrell Martha is listed as CHIEF MEDICAL OFFICER at NeuroPace Inc. Inside the rolling window, Morrell Martha reported no open-market purchases and 1 open-market sale totaling $399K in NPCE.
Companies traded
Other insiders at NPCE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$399K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Morrell Martha made?
Morrell Martha has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Morrell Martha trade?
Morrell Martha has filed SEC Form 4 disclosures for 1 company, including NPCE.
When was Morrell Martha's most recent SEC Form 4 filing?
Morrell Martha's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.
What is Morrell Martha's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Morrell Martha is listed as CHIEF MEDICAL OFFICER.
What is Morrell Martha's total buy and sell value in the current window?
Inside the rolling retention window, Morrell Martha bought $0 and sold $399K based on SEC Form 4 filings.
What was Morrell Martha's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 NPCE shares on 2025-12-15, worth $399K, per SEC Form 4 filings.